Beazley and Chaucer have been working with Gaia to design a new underwriting approach for IVF treatment within the UK.
Gaia said that the product will be led by Beazley with further support provided by Chaucer and Atrium. Meanwhile, it has been appointed as a Lloyd’s Coverholder.
George Beattie, head of incubation underwriting at Beazley, said: “The Gaia proposition is unique because it represents the embedded digital distribution of a completely new type of insurance product. The Gaia solution also caters for a market that is set to grow exponentially in the coming years as fertility levels continue to decline globally. For many, accessing IVF treatment is fraught with confusion, a requirement to have significant savings to start treatment and a lack of transparency around options and outcomes.
He added: “We are delighted to have a partner that is aiming to change the status quo and to help people realise their dreams. Although our insurance product cannot mitigate the personal implications of an IVF program not being successful, our aim is to play a positive role by at least removing the financial concern of having to pay for treatment fees following failure and by helping individuals get the counselling support they need.”
Gaia’s product leverages millions of data points to predict personalised success rates for IVF treatment, which the company says can provide people with transparency, community, and access to IVF services from a range of clinics via an innovative mobile app and website.
The product covers eligible Gaia members for their treatment fees in the event their IVF treatment program is unsuccessful. Policyholders are also offered a fund that can be used to pay for counselling costs.
The product is now available in the UK.
